COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Funding Opportunities

The NIH Human Connectome Project (HCP) is an ambitious effort to develop and share knowledge about the structural and functional connectivity of the human brain. Beginning in 2010, Blueprint has funded a range of projects to reveal the patterns of connections in the human brain at a number of developmental stages, and in health and disease states. In addition, the Connectome Coordination Facility, funded by Blueprint in 2015, maintains a central data repository for HCP data and offers advice to the research community regarding data collection strategies and harmonization. Additional information about these projects can be found by clicking on the titles, below.

SHOW RESULTS FILTERED BY:
SEARCH RESULTS
Title Number News Date Expiration Date Category
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-20-111 March 03, 2020 May 08, 2023 Neurotherapeutics
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) PAR-20-122 March 03, 2020 May 08, 2023 Neurotherapeutics
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) NOT-NS-20-032 January 06, 2020 January 01, 2023
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) NOT-NS-20-032 January 06, 2020 January 01, 2022 Neurotherapeutics
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) NOT-NS-20-033 January 06, 2020 January 03, 2022 Neurotherapeutics
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional PAR-18-541 December 21, 2017 May 08, 2020 Neurotherapeutics
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional PAR-18-546 December 21, 2017 May 08, 2020 Neurotherapeutics
Notice of National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Drug Abuse (NIDA) Interest in Blueprint Neurotherapeutic Network Applications Directed at Small Molecule Non-Addictive Pain Therapies NOT-NS-18-027 December 13, 2017 January 01, 2021 Neurotherapeutics
NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33Clinical Trial Not Allowed) RFA-MH-18-600 November 03, 2017 January 23, 2018
Title Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels (R01) RFA-NS-18-003 September 18, 2017 December 12, 2017